Fifth International Symposium on ARSACS Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)

The Montreal Neurological Institute is hosting an international symposium to discuss the advances in our understanding of ARSACS (Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay). This two day symposium will take place on October 31 and November 1, 2018 at the Montreal Neurological. The symposium will bring together clinical experts, ataxia experts, mitochondrial experts actively working on ARSACS. This meeting marks a turning point for ARSACS research since it will coincide with the in-person meeting of the ERare PREPARE consortium on recessive ataxias. The consortium is led by Matthis Synofzik of Tübingen. Set up in 2016, as its name suggests PREPARE is focused on preparing the recessive ataxias to an expected therapeutic transformation by building shared tools to follow patient cohorts, collect biological materials, generate on demand fly models and continue to push for pre-clinical trials. It is no coincidence that the two meetings will follow each other, since ARSACS is a flagship ataxia for PREPARE. A half day of the symposium will consist of presentations on ongoing ARSACS work done by PREPARE members to the broader ARSACS international community. It is sponsored by the Ataxia of Charlevoix-Saguenay Foundation and Ataxia of Charlevoix-Saguenay Foundation and CIHR Institute of Genetics New Emerging Team on ARSACS.

Register online here.

The Montreal Neurological Institute & Hospital is a McGill University research and teaching institute; delivering the highest quality of care to patients, as part of the Neuroscience Mission of the McGill University Health Centre. The MNI is proud to be a Killam Institution, supported by the Killam Trusts.